{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:21:21Z","timestamp":1793740881197,"version":"4.6.1"},"reference-count":62,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203434"],"award-info":[{"award-number":["82203434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473106"],"award-info":[{"award-number":["82473106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473391"],"award-info":[{"award-number":["82473391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["YDZX20243100002003"],"award-info":[{"award-number":["YDZX20243100002003"]}]},{"name":"China Post-doc science Foundation","award":["2021M690698"],"award-info":[{"award-number":["2021M690698"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0525500\/2024ZD0525501\/2024ZD0525505"],"award-info":[{"award-number":["2024ZD0525500\/2024ZD0525501\/2024ZD0525505"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,12,17]]},"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over 90% pancreatic cancers harbour activating kirsten rat sarcoma viral oncogene homolog (KRAS\uff09mutations. However, monotherapies targeting the KRAS vertical pathway, with recently developed KRAS inhibitors or rapidly accelerated fibrosarcoma (RAF)\/MEK\/ERK inhibitors, have demonstrated limited clinical benefit. Therefore, there is an urgent need to identify novel therapeutic targets and combination strategies with KRAS inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to identify pharmaceutical targets whose inhibition suppresses pancreatic ductal adenocarcinoma (PDAC) or potentiates KRAS inhibition, focusing on molecular vulnerabilities specific to KRAS-mutant PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Designs<\/jats:title>\n                    <jats:p>We integrated genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)\/Cas9 (CRISPR-associated Protein 9) dropout screens, large-scale genomic dependency datasets and pharmacological screens to identify molecular vulnerabilities in KRAS-mutant PDAC. Conditional knockout mouse models were used to assess the essentiality of candidate genes in pancreatic cancer. RNA sequencing, metabolomics\/proteomics analysis and stable isotopic tracing were employed to investigate mechanisms underlying inosine monophosphate dehydrogenase 2 (IMPDH2) vulnerability. Additionally, proteolysis-targeting chimaera compounds targeting IMPDH2 were developed and evaluated in patient-derived organoid and xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Integrated screens revealed de novo guanine nucleotide biosynthesis (DNGB) as a vulnerability in KRAS-mutant PDAC, with\n                      <jats:italic>IMPDH2<\/jats:italic>\n                      being the critical gene. Unexpectedly, IMPDH2 expression and activity are not driven by the KRAS vertical pathway. Consequently, IMPDH2 inhibition induces irreversible guanine nucleotide depletion that cannot be compensated for by mutant KRAS. Inducing guanine nucleotide depletion via targeting IMPDH2 for degradation inhibits PDAC and augments KRAS inhibitor efficacy in vitro and in vivo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide a rationale for developing combination therapies targeting KRAS and DNGB, highlighting the potential of purine nucleotide imbalance as a biomarker to guide the application of these therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-336235","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:20:34Z","timestamp":1767723634000},"page":"2156-2170","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-563X","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9580-6600","authenticated-orcid":false,"given":"Chunbin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2104-1892","authenticated-orcid":false,"given":"Haoqi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-3186","authenticated-orcid":false,"given":"He","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-8604","authenticated-orcid":false,"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7722-6389","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7487-6836","authenticated-orcid":false,"given":"Sikai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0862-2501","authenticated-orcid":false,"given":"Mingming","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-7143","authenticated-orcid":false,"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-0629","authenticated-orcid":false,"given":"Si","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai, China"},{"name":"Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2026100702350703000_75.11.2156.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2026100702350703000_75.11.2156.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00375-9"},{"key":"2026100702350703000_75.11.2156.3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2425"},{"key":"2026100702350703000_75.11.2156.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.058"},{"key":"2026100702350703000_75.11.2156.5","unstructured":"Wasko UN , Jiang J , Dalton TC , et al . Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature New Biol 2024."},{"key":"2026100702350703000_75.11.2156.6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy","volume":"629","author":"Holderfield","year":"2024","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02007-7"},{"key":"2026100702350703000_75.11.2156.8","doi-asserted-by":"crossref","unstructured":"Moore AR , Rosenberg SC , McCormick F , et al . RAS-targeted therapies. Nat Rev Drug Discov 2021. doi:10.1038\/s41573-021-00220-6","DOI":"10.1038\/s41573-021-00220-6"},{"key":"2026100702350703000_75.11.2156.9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.10","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk0850","article-title":"Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2026100702350703000_75.11.2156.11","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk0775","article-title":"Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2026100702350703000_75.11.2156.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-2729"},{"key":"2026100702350703000_75.11.2156.13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1274"},{"key":"2026100702350703000_75.11.2156.14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-25-0349"},{"key":"2026100702350703000_75.11.2156.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.017"},{"key":"2026100702350703000_75.11.2156.16","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3390\/cancers14122837","article-title":"Synthetic Vulnerabilities in the KRAS Pathway","volume":"14","author":"Roman","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026100702350703000_75.11.2156.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.02.038"},{"key":"2026100702350703000_75.11.2156.18","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110611","article-title":"Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061","volume":"41","author":"Vit","year":"2022","journal-title":"EMBO J"},{"key":"2026100702350703000_75.11.2156.19","doi-asserted-by":"crossref","unstructured":"Liao L-X , Song X-M , Wang L-C , et al . Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy. Proc Natl Acad Sci USA 2017;114. doi:10.1073\/pnas.1706778114","DOI":"10.1073\/pnas.1706778114"},{"key":"2026100702350703000_75.11.2156.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.010"},{"key":"2026100702350703000_75.11.2156.21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3984"},{"key":"2026100702350703000_75.11.2156.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06916-5"},{"key":"2026100702350703000_75.11.2156.23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/hep4.1559","article-title":"Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression","volume":"4","author":"Chong","year":"2020","journal-title":"Hepatol Commun"},{"key":"2026100702350703000_75.11.2156.24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-024-08224-z","article-title":"Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma","volume":"636","author":"Chen","year":"2024","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1476-4598-13-154","article-title":"Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells","volume":"13","author":"Arozarena","year":"2014","journal-title":"Mol Cancer"},{"key":"2026100702350703000_75.11.2156.26","doi-asserted-by":"crossref","first-page":"115116","DOI":"10.1016\/j.celrep.2024.115116","article-title":"IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth","volume":"44","author":"Zhou","year":"2025","journal-title":"Cell Rep"},{"key":"2026100702350703000_75.11.2156.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53877-z"},{"key":"2026100702350703000_75.11.2156.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.01.077"},{"key":"2026100702350703000_75.11.2156.29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41586-018-0291-z","article-title":"CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions","volume":"559","author":"Zimmermann","year":"2018","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1246981"},{"key":"2026100702350703000_75.11.2156.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1247005"},{"key":"2026100702350703000_75.11.2156.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00309-X"},{"key":"2026100702350703000_75.11.2156.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0455-6"},{"key":"2026100702350703000_75.11.2156.34","doi-asserted-by":"crossref","unstructured":"Johnson MC , Kollman JM . Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife 2020.","DOI":"10.7554\/eLife.53243.sa2"},{"key":"2026100702350703000_75.11.2156.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0363-9"},{"key":"2026100702350703000_75.11.2156.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)74247-1"},{"key":"2026100702350703000_75.11.2156.37","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00026-V"},{"key":"2026100702350703000_75.11.2156.38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/256331a0","article-title":"IMP dehydrogenase, an enzyme linked with proliferation and malignancy","volume":"256","author":"Jackson","year":"1975","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.39","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)90150-3"},{"key":"2026100702350703000_75.11.2156.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00557-7"},{"key":"2026100702350703000_75.11.2156.41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz6465"},{"key":"2026100702350703000_75.11.2156.42","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12947","article-title":"SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice","volume":"18","author":"Zhao","year":"2019","journal-title":"Aging Cell"},{"key":"2026100702350703000_75.11.2156.43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature New Biol"},{"key":"2026100702350703000_75.11.2156.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-022-00965-1"},{"key":"2026100702350703000_75.11.2156.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.001"},{"key":"2026100702350703000_75.11.2156.46","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0507"},{"key":"2026100702350703000_75.11.2156.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0024-8"},{"key":"2026100702350703000_75.11.2156.48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081632"},{"key":"2026100702350703000_75.11.2156.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"2026100702350703000_75.11.2156.50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132939"},{"key":"2026100702350703000_75.11.2156.51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","article-title":"Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer","volume":"1","author":"Steele","year":"2020","journal-title":"Nat Cancer"},{"key":"2026100702350703000_75.11.2156.52","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-129251","article-title":"Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase","volume":"21","author":"Sohbati","year":"2022","journal-title":"Iran J Pharm Res"},{"key":"2026100702350703000_75.11.2156.53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.celrep.2016.12.030","article-title":"IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex","volume":"18","author":"Pua","year":"2017","journal-title":"Cell Rep"},{"key":"2026100702350703000_75.11.2156.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.05.011"},{"key":"2026100702350703000_75.11.2156.55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091346","article-title":"Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story","volume":"11","author":"Naffouje","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2026100702350703000_75.11.2156.56","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329349"},{"key":"2026100702350703000_75.11.2156.57","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1534\/g3.117.041277","article-title":"Evaluation and Design of Genome-Wide CRISPR\/SpCas9 Knockout Screens","volume":"7","author":"Hart","year":"2017","journal-title":"G3 Genes|Genomes|Genetics"},{"key":"2026100702350703000_75.11.2156.58","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol"},{"key":"2026100702350703000_75.11.2156.59","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol"},{"key":"2026100702350703000_75.11.2156.60","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1097\/SLA.0000000000003884","article-title":"Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms","volume":"275","author":"Hua","year":"2022","journal-title":"Ann Surg"},{"key":"2026100702350703000_75.11.2156.61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk6633","article-title":"PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells","volume":"10","author":"Xu","year":"2024","journal-title":"Sci Adv"},{"key":"2026100702350703000_75.11.2156.62","doi-asserted-by":"publisher","DOI":"10.1038\/srep13099"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-336235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:37:15Z","timestamp":1791365835000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-336235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/gutjnl-2025-336235"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-336235","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}